Collection 2018/09-10

Start date: 26.02.2018

Original article

Steiner R, Kridel R, Giostra E, McKee T, Achermann R, Mueller N, Manuel O, Dickenmann M, Schuurmans MM, de Leval L, Fehr T, Tinguely M, Binet I, Cogliatti S, Haralamvieva E, Koller M, the Swiss Transplant Cohort Study (STCS), Dietrich PY

Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland

Swiss Med Wkly. 2018;148:w14596

Post-transplant lymphoproliferative disorder (PTLD) is a potentially life-threatening complication of immunosuppression and oncogenic viral infections.

Passweg JR, Baldomero H, Ansari M, Baerlocher GM, Bargetzi M, Chalandon Y, Duchosal MA, Gerull S, Güngör T, Halter JP, Heim D, Hess U, Leibundgut K, Masouridi-Levrat S, Müller A, Nair G, Pabst T, Renner C, Schmidt A, Stussi G, Nicoloso de Faveri G, Schanz U, for the Swiss Blood Stem Cell Transplantation Group (SBST)

Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997–2016

Swiss Med Wkly. 2018;148:w14589

Federal regulations in Switzerland have made it mandatory to maintain a registry including all heamatopietic stem cell transplants performed in the country.

Verpassen Sie keinen Artikel!

close